Green Tea (Camellia sinensis): A Review of Its Phytochemistry, Pharmacology, and Toxicology

• Published in: Molecules (Basel, Switzerland) Vol. 27; no. 12; p. 3909
• Main Authors: Zhao, Tiantian, Li, Chao, Wang, Shuai, Song, Xinqiang
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 18.06.2022; MDPI
• Subjects: Amino acids; Antioxidants; Antiviral drugs; Caffeine; Cancer; Cardiovascular disease; Diabetes; Flavonoids; green tea; human health; Nervous system; Older people; Oral cancer; Pharmacology; phytochemistry; Polyphenols; Review; Tea; Toxicology; unfermented tea; China
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules27123909

Objectives Green tea (Camellia sinensis) is a kind of unfermented tea that retains the natural substance in fresh leaves to a great extent. It is regarded as the second most popular drink in the world besides water. In this paper, the phytochemistry, pharmacology, and toxicology of green tea are reviewed systematically and comprehensively. Key findings Green tea has been demonstrated to be good for human health. Nowadays, multiple pharmacologically active components have been isolated and identified from green tea, including tea polyphenols, alkaloids, amino acids, polysaccharides, and volatile components. Recent studies have demonstrated that green tea shows versatile pharmacological activities, such as antioxidant, anticancer, hypoglycemic, antibacterial, antiviral, and neuroprotective. Studies on the toxic effects of green tea extract and its main ingredients have also raised concerns including hepatotoxicity and DNA damage. Summary Green tea can be used to assist the treatment of diabetes, Alzheimer’s disease, oral cancer, and dermatitis. Consequently, green tea has shown promising practical prospects in health care and disease prevention.